Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 726-750 of 798 matching filings.

Per page
25
Current page
30
4

FORM 4 SUBMISSION

Filing date
23 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
15 May 2014
Reporting date
13 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35921

AUTO-GENERATED PAPER DOCUMENT

Filing date
18 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35921

DEF 14A

Filing date
17 Apr 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
10 Apr 2014
Reporting date
04 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
21 Mar 2014
Reporting date
19 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Mar 2014
Reporting date
19 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
21 Mar 2014
Reporting date
19 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
17 Mar 2014
Reporting date
17 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2014
Reporting date
04 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2014
Reporting date
19 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SC 13G

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SCHEDULE 13G

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SC 13G filing

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SCHEDULE 13G

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
05 Feb 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 Feb 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

SC 13G filing

Filing date
16 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2013
Reporting date
16 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Nov 2013
Reporting date
26 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Nov 2013
Reporting date
08 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .